Bengal & Assam Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 6, 2025, 10:54 pm

Competitors of Bengal & Assam Company Ltd

All Competitor Stocks of Bengal & Assam Company Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:25 pm

Below is a detailed analysis of the quarterly data for Bengal & Assam Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 573.00 Cr.. The value appears strong and on an upward trend. It has increased from 521.00 Cr. (Mar 2025) to 573.00 Cr., marking an increase of 52.00 Cr..
• For Expenses, as of Jun 2025, the value is 472.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 428.00 Cr. (Mar 2025) to 472.00 Cr., marking an increase of 44.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 101.00 Cr.. The value appears strong and on an upward trend. It has increased from 93.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 8.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00%.
• For Other Income, as of Jun 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2025) to 27.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 16.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 17.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 93.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 28.00%.
• For Net Profit, as of Jun 2025, the value is 258.00 Cr.. The value appears strong and on an upward trend. It has increased from 231.00 Cr. (Mar 2025) to 258.00 Cr., marking an increase of 27.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 219.05. The value appears strong and on an upward trend. It has increased from 197.56 (Mar 2025) to 219.05, marking an increase of 21.49.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:47 am

Growth

Last Updated: September 5, 2025, 2:36 pm

Balance Sheet

Last Updated: December 4, 2025, 2:30 am

Below is a detailed analysis of the balance sheet data for Bengal & Assam Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
• For Reserves, as of Sep 2025, the value is 10,199.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,750.00 Cr. (Mar 2025) to 10,199.00 Cr., marking an increase of 449.00 Cr..
• For Borrowings, as of Sep 2025, the value is 559.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 556.00 Cr. (Mar 2025) to 559.00 Cr., marking an increase of 3.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,056.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,019.00 Cr. (Mar 2025) to 1,056.00 Cr., marking an increase of 37.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 11,826.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,336.00 Cr. (Mar 2025) to 11,826.00 Cr., marking an increase of 490.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 472.00 Cr.. The value appears to be declining and may need further review. It has decreased from 480.00 Cr. (Mar 2025) to 472.00 Cr., marking a decrease of 8.00 Cr..
• For CWIP, as of Sep 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Sep 2025, the value is 10,322.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,869.00 Cr. (Mar 2025) to 10,322.00 Cr., marking an increase of 453.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,008.00 Cr.. The value appears strong and on an upward trend. It has increased from 962.00 Cr. (Mar 2025) to 1,008.00 Cr., marking an increase of 46.00 Cr..
• For Total Assets, as of Sep 2025, the value is 11,826.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,336.00 Cr. (Mar 2025) to 11,826.00 Cr., marking an increase of 490.00 Cr..

Notably, the Reserves (10,199.00 Cr.) exceed the Borrowings (559.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bengal & Assam Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 642.14. This value is within the healthy range. It has decreased from 3,444.99 (Mar 24) to 642.14, marking a decrease of 2,802.85.
• For Diluted EPS (Rs.), as of Mar 25, the value is 632.65. This value is within the healthy range. It has decreased from 3,444.99 (Mar 24) to 632.65, marking a decrease of 2,812.34.
• For Cash EPS (Rs.), as of Mar 25, the value is 325.45. This value is within the healthy range. It has decreased from 3,399.57 (Mar 24) to 325.45, marking a decrease of 3,074.12.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8,641.35. It has increased from 8,180.76 (Mar 24) to 8,641.35, marking an increase of 460.59.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8,641.35. It has increased from 8,180.76 (Mar 24) to 8,641.35, marking an increase of 460.59.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,883.71. It has decreased from 11,435.08 (Mar 24) to 1,883.71, marking a decrease of 9,551.37.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 442.66. This value is within the healthy range. It has decreased from 1,726.19 (Mar 24) to 442.66, marking a decrease of 1,283.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 382.06. This value is within the healthy range. It has decreased from 1,395.90 (Mar 24) to 382.06, marking a decrease of 1,013.84.
• For PBT / Share (Rs.), as of Mar 25, the value is 354.28. This value is within the healthy range. It has decreased from 3,637.68 (Mar 24) to 354.28, marking a decrease of 3,283.40.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 264.85. This value is within the healthy range. It has decreased from 3,069.28 (Mar 24) to 264.85, marking a decrease of 2,804.43.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 648.25. This value is within the healthy range. It has decreased from 3,444.99 (Mar 24) to 648.25, marking a decrease of 2,796.74.
• For PBDIT Margin (%), as of Mar 25, the value is 23.49. This value is within the healthy range. It has increased from 15.09 (Mar 24) to 23.49, marking an increase of 8.40.
• For PBIT Margin (%), as of Mar 25, the value is 20.28. This value exceeds the healthy maximum of 20. It has increased from 12.20 (Mar 24) to 20.28, marking an increase of 8.08.
• For PBT Margin (%), as of Mar 25, the value is 18.80. This value is within the healthy range. It has decreased from 31.81 (Mar 24) to 18.80, marking a decrease of 13.01.
• For Net Profit Margin (%), as of Mar 25, the value is 14.05. This value exceeds the healthy maximum of 10. It has decreased from 26.84 (Mar 24) to 14.05, marking a decrease of 12.79.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.41. This value exceeds the healthy maximum of 20. It has increased from 30.12 (Mar 24) to 34.41, marking an increase of 4.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.50. This value is below the healthy minimum of 15. It has decreased from 42.97 (Mar 24) to 7.50, marking a decrease of 35.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 10. It has decreased from 16.17 (Mar 24) to 4.11, marking a decrease of 12.06.
• For Return On Assets (%), as of Mar 25, the value is 6.44. This value is within the healthy range. It has decreased from 37.16 (Mar 24) to 6.44, marking a decrease of 30.72.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.19. It has decreased from 0.92 (Mar 24) to 0.19, marking a decrease of 0.73.
• For Current Ratio (X), as of Mar 25, the value is 12.17. This value exceeds the healthy maximum of 3. It has decreased from 13.61 (Mar 24) to 12.17, marking a decrease of 1.44.
• For Quick Ratio (X), as of Mar 25, the value is 11.76. This value exceeds the healthy maximum of 2. It has decreased from 13.09 (Mar 24) to 11.76, marking a decrease of 1.33.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.74. This value is within the healthy range. It has increased from 4.68 (Mar 24) to 5.74, marking an increase of 1.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.17. This value is below the healthy minimum of 20. It has increased from 0.72 (Mar 24) to 6.17, marking an increase of 5.45.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.64. This value is below the healthy minimum of 20. It has increased from 0.66 (Mar 24) to 5.64, marking an increase of 4.98.
• For Earning Retention Ratio (%), as of Mar 25, the value is 93.83. This value exceeds the healthy maximum of 70. It has decreased from 99.28 (Mar 24) to 93.83, marking a decrease of 5.45.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.36. This value exceeds the healthy maximum of 70. It has decreased from 99.34 (Mar 24) to 94.36, marking a decrease of 4.98.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.40. This value is within the healthy range. It has increased from 5.35 (Mar 24) to 11.40, marking an increase of 6.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.54. This value is within the healthy range. It has increased from 2.56 (Mar 24) to 7.54, marking an increase of 4.98.
• For Enterprise Value (Cr.), as of Mar 25, the value is 8,809.28. It has decreased from 10,221.95 (Mar 24) to 8,809.28, marking a decrease of 1,412.67.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.14. This value exceeds the healthy maximum of 3. It has increased from 0.79 (Mar 24) to 4.14, marking an increase of 3.35.
• For EV / EBITDA (X), as of Mar 25, the value is 17.62. This value exceeds the healthy maximum of 15. It has increased from 5.24 (Mar 24) to 17.62, marking an increase of 12.38.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.83. This value exceeds the healthy maximum of 3. It has increased from 0.74 (Mar 24) to 3.83, marking an increase of 3.09.
• For Retention Ratios (%), as of Mar 25, the value is 93.82. This value exceeds the healthy maximum of 70. It has decreased from 99.27 (Mar 24) to 93.82, marking a decrease of 5.45.
• For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 1.07 (Mar 24) to 0.83, marking a decrease of 0.24.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.83. This value exceeds the healthy maximum of 3. It has increased from 0.74 (Mar 24) to 3.83, marking an increase of 3.09.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.40 (Mar 24) to 0.08, marking a decrease of 0.32.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness